Global /Japan /Healthcare /Drug Manufacturers - General /368A

Kitazato Corp.

368A

• TSE: 368A • Delayed

1,375JPY 5.3%

8.58 USD

As of 8 June 2026, Kitazato Corp. has a market cap of $326.45M USD, ranking #18058 globally and #1368 in Japan. It ranks #1640 in the Healthcare sector, and #590 in the Drug Manufacturers - General industry.

Global Rank

18058

Country Rank

1368

Sector Rank

1640

Industry Rank

590

Key Stats

Market Cap

$326.45MUSD

52.24B JPY

Enterprise Value

$251.07MUSD

40.21B JPY

Revenue (TTM)

$68.6MUSD

10.98B JPY

Net Income (TTM)

$24.9MUSD

3.98B JPY

PE Ratio

13.1

Forward PE

13.1

PS Ratio

4.8

PB Ratio

2.7

Company Profile

Country (HQ)

Japan

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Futoshi Inoue open_in_new

Employees

Founded

1998

Website

kitazato.co.jp open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
5.3%	-1.5%	-3.8%	-12%	-5.4%	-14%	-40%	-40%	-40%

News

Markets

Exchange	Ticker	Price	Quotes
Tokyo Stock Exchange (TSE / TYO) MIC: XTKS PRIMARY	368A ISIN: JP3237550003 Shares Out.: Shares Outstanding: 40.0M¹ Shares Float: 16.1M² TV: TradingView: TSE: 368A SA: Stock Analysis: TYO: 368A YF: Yahoo Finance: 368A.T GF: Google Finance: TYO: 368A BA: Barron's: 368A MS: Morningstar: XTKS: 368A	1,375 JPY	TV: TradingView: TSE: 368A SA: Stock Analysis: TYO: 368A YF: Yahoo Finance: 368A.T GF: Google Finance: TYO: 368A BA: Barron's: 368A MS: Morningstar: XTKS: 368A

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Kitazato Corp.

Kitazato Corporation researches, develops, manufactures, and markets medical devices and related products for fertility treatment. It offers needles, catheters and cannulas, vitrification media and equipment, sperm processing medium/tools, IVF medium products, micro tools, and labware products. The company was formerly known as Kitazato Biopharma Co., Ltd. The company was founded in 1998 and is based in Shizuoka, Japan. Kitazato Corporation is a subsidiary of Kitasato Shoji Co., Ltd.

Similar Companies

Industry: Drug Manufacturers - General (Japan)

Name	Market Cap (USD) diff.	PE	Country
Chugai Pharmaceutical Co., Ltd. TSE: 4519	$81.66B 13.07T JPY 25K%	28.9	Japan
Takeda Pharmaceutical Company Ltd. TSE: 4502	$52.21B 8.36T JPY 16K%	75.1	Japan
Otsuka Holdings Co., Ltd. TSE: 4578	$36.84B 5.9T JPY 11K%	15.7	Japan
Daiichi Sankyo Company, Ltd. TSE: 4568	$30.37B 4.86T JPY 9K%	16.2	Japan
Astellas Pharma Inc. TSE: 4503	$25.82B 4.13T JPY 8K%	14.2	Japan
Shionogi & Co., Ltd. TSE: 4507	$16.91B 2.71T JPY 5K%	13.9	Japan

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 233K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 168K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 110K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 99K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 89K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 85K%	20.5	Switzerland

chevron_leftBack